Source : CEDICT

Lamivudine, reverse transcriptase inhibitor marketed by GlaxoSmithKline and widely used in the treatment of hepatitis B and AIDS/brand names include Zeffix, Heptovir, Epivir and Epivir-HBV

Source : CEDICT

Lamivudine, reverse transcriptase inhibitor marketed by GlaxoSmithKline and widely used in the treatment of hepatitis B and AIDS/brand names include Zeffix, Heptovir, Epivir and Epivir-HBV